indapamide hemihydrate - medicine shortage information

Back to ALL shortages and discontinuations    Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Product details Supply Impact Dates Further Details
DAPA-TABS indapamide hemihydrate 2.5 mg tablet blister pack
AUST R: 62367
Active ingredients:
indapamide hemihydrate

Dosage form:
Tablet

Sponsor:
Alphapharm Pty Ltd

Phone:
1800274276

From
06 Sep 2024
to
01 Oct 2024

Shortage status:
Resolved

Availability:
Available

Reason:
Manufacturing

IDAPREX COMBI 4/1.25 perindopril erbumine 4mg and indapamide hemihydrate 1.25mg tablet blister pack
AUST R: 94527
Active ingredients:
indapamide hemihydrate
perindopril erbumine

Dosage form:
Tablet, uncoated

Sponsor:
Servier Laboratories (Aust) Pty Ltd

Phone:
1800726369

Deletion from market:
30 Apr 2025

Shortage status:
To be discontinued

Availability:
Reduction in supply until supply is exhausted

Reason:
Commercial Changes / Commercial viability

INDOSYL COMBI 4/1.25 perindopril erbumine 4mg / indapamide hemihydrate 1.25mg tablet blister pack
AUST R: 74137
Active ingredients:
indapamide hemihydrate
perindopril erbumine

Dosage form:
Tablet, uncoated

Sponsor:
Servier Laboratories (Aust) Pty Ltd

Phone:
1300 927 769

Deletion from market:
31 Jan 2025

Shortage status:
To be discontinued

Availability:
Reduction in supply until supply is exhausted

Reason:
Commercial Changes / Commercial viability